MicrOsmium Inc
Custom Synthesis
Our company Legal and Operating Names: MicrOsmium Inc Québec Enterprise Number (NEQ): 1170041751 Mailing Address 636, route 210 Cookshire-Eaton, Qc J0B 1M0 Canada
Location Address 3001, 12th Ave N Sherbrooke, Qc J1H 5N4 Canada
Telephone: +1 (819) 564 5299 Fax: +1 (819) 564 5400 Email:
[email protected] Website URL: under construction Yves L. Dory Title: President and CEO Telephone: +1 (819) 564 5299 Email:
[email protected] Date Established: 2014 May 5th Facilities: a) 2 full-equipped top-notch laboratories capable of accommodating 12 HQPs b) 300 MHz NMR spectrometer c) Several LC-MS spectrometers d) Brand new peptide synthesizer
One of our 2 busy laboratories
NMR spectrometers
Brief History and Assets: MicrOsmium Inc is a very young company hosted inside the Institute of Pharmacology of Sherbrooke (IPS). For this reason, we are already fully operational since we have access to all
MicrOsmium Inc
Custom Synthesis
the facilities required to carry out challenging syntheses of all kinds. Moreover, we benefit from a stimulating environment of around 200 active scientists in many life sciences related areas.
The Institute of Pharmacology of Sherbrooke where MicrOsmium is located
Our 2 new laboratories
Who we are Microsmium is a privately owned Canadian company, located in the Eastern Townships of the province of Québec, in Canada. Our team of scientists specialized in organic synthesis, mainly Ph.D.s, are willing to take on customer's challenges to develop and produce tailor-made compounds in milligrams to grams quantities for the pharmaceutical and biotechnology industry. We are experienced in delivering natural amino acid derivatives as well as functionalized heterocycles and especially macrocyclic compounds.
MicrOsmium Inc
Custom Synthesis
About the Founder, President and CEO: Yves L. Dory grew up near the beautiful maritime town of St-Malo, in Brittany, France. He pursued his undergraduate education at the University of Rennes, still in France. He crossed the English Channel to Southampton, UK, where he obtained his Ph.D. in 1988 with Professor J. M. Mellor at the University of Southampton. Yves then crossed the Atlantic Ocean to train as a PDF with Professor Pierre Deslongchamps at the Université de Sherbrooke in the province of Québec, Canada. There, he spent much of his time studying transannular Diels-Alders reactions inside 14-membered macrocycles. After a short stay in France in 1990, he moved back to Canada, where he was hired as head of a medicinal chemistry team in Endorecherche inc, a medicinal research company located in Quebec City. Since June of 1993, Yves has been at the Université de Sherbrooke where he is now a full Professor of Chemistry and where his group (1 MSc, 6 PhD, 2 PDF and 1 RA) explores supramolecular architectures and medicinal chemistry as well as mechanisms of selected organic reactions by means of molecular modeling tools. He has been actively involved in the creation of Néokimia/Tranzyme Pharma (Sherbrooke, 1997-9) as a director of medicinal chemistry and in the writing of the original scientific business plan. He is the co-author of 70 scientific publications and the co-inventor on 10 patents. He recently joined a prestigious transatlantic collaborative team with researchers from Canada, France and Sweden (Leducq Foundation) to study the PCSQ9 enzyme as a target for the treatment of hypercholesterolemia, a health disorder responsible for many deaths in developed countries. Our mission We are committed to delivering superior customer service to the pharmaceutical industry, by providing high quality products. Our vision We are growth oriented and aim at extending our products and services to the worldwide pharmaceutical and biotechnological industry. We will reach this goal by continuously developing our competences, increasing our capacity to meet cutting edge technological demands and attracting, developing and motivating the best scientists around. Our values Collaboration We promote team work across the organization and with our business partners. We continuously strive for flexibility, responsiveness and sharing of information. Quality We are result oriented and aim for excellence in our products and services as well as the way we achieve them. Minimizing costs and lead time is one major commitment. Integrity We respect confidentiality and intellectual property of our customers. People We believe in equal opportunity and treat customers and employees with dignity and respect. We promote a multicultural environment and cultivate individual talents.
MicrOsmium Inc
Custom Synthesis
Our payment information Payment Terms from Invoice: 75 days Bank Name: Bank of Montreal Institution Number: 001 Branch Transit Number: 0113 Pre-Authorized Debit/Credit (PAD/PAC) Number: 01131 Account Number: 1015071 Wire Payment (from Outside Canada and USA): SWIFT BIC Code: BOFMCAM2 Address: 110, Rue Principale Cookshire, Qc J0B 1M0 Canada
About our products MicrOsmium can synthesize many types of molecules as shown by some selected compounds recently made at our facilities (see figure below and additional file named MicrOsmium CS.pdf) We can make pure TTF in large quantities (10s of grams)